Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $20.2 million.

  • Cellebrite DI's Net Income towards Common Stockholders rose 10987.06% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.3 million, marking a year-over-year increase of 12446.09%. This contributed to the annual value of -$283.0 million for FY2024, which is 24896.05% down from last year.
  • As of Q3 2025, Cellebrite DI's Net Income towards Common Stockholders stood at $20.2 million, which was up 10987.06% from $19.5 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Net Income towards Common Stockholders high stood at $54.5 million for Q1 2022, and its period low was -$204.5 million during Q3 2024.
  • For the 5-year period, Cellebrite DI's Net Income towards Common Stockholders averaged around -$5.6 million, with its median value being $8.1 million (2021).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 165595.8% in 2021, then tumbled by 308637.76% in 2024.
  • Over the past 5 years, Cellebrite DI's Net Income towards Common Stockholders (Quarter) stood at $51.9 million in 2021, then plummeted by 82.45% to $9.1 million in 2022, then crashed by 235.63% to -$12.3 million in 2023, then surged by 256.09% to $19.3 million in 2024, then increased by 4.77% to $20.2 million in 2025.
  • Its last three reported values are $20.2 million in Q3 2025, $19.5 million for Q2 2025, and $17.4 million during Q1 2025.